Stock Comparison
ABT vs PODD
Abbott Laboratories and Insulet Corporation side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$192.35B
$10.04B
P/E (TTM)
35.7
27.1
Forward P/E
20.0
23.9
Price/Sales
4.1
3.3
Price/Book
3.7
7.1
EV/EBITDA
18.6
16.0
Dividend Yield
1.66%
—
Profitability
Net Margin
13.91%
10.44%
Operating Margin
18.17%
17.48%
Return on Equity
10.60%
26.00%
Return on Assets
5.33%
9.72%
Growth (YoY)
Revenue Growth
13.00%
23.50%
Earnings Growth
-47.50%
328.60%
Price & Risk
Beta
0.6
1.1
52-Week High
$134.48
$352.82
52-Week Low
$82.56
$133.26
Analyst Target
$118.42
$171.91
Compare ABT and PODD your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.